- Home
- ANVS vs FONR Comparison
ANVS vs FONR Comparison
Compare ANVS & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANVS | FONR |
|---|---|---|
| Founded | 2008 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.3M | 117.8M |
| IPO Year | 2019 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ANVS | FONR |
|---|---|---|
| Price | $2.62 | $18.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 338.3K | 50.8K |
| Earning Date | 03-16-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.39 | N/A |
| EPS | N/A | ★ 1.16 |
| Revenue | N/A | ★ $104,351,318.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.90 |
| Revenue Growth | N/A | ★ 1.43 |
| 52 Week Low | $1.11 | $12.00 |
| 52 Week High | $5.50 | $18.86 |
Technical Indicators
Market Signals| Indicator | ANVS | FONR |
|---|---|---|
| Relative Strength Index (RSI) | 49.37 | 46.71 |
| Support Level | $2.29 | $18.31 |
| Resistance Level | $2.63 | $18.65 |
| Average True Range (ATR) | 0.22 | 0.08 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 44.73 | 31.67 |
Price Performance
Historical ComparisonAbout ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.